Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

81.81 +2.65 (+3.35%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,800,818
Open 78.96
Bid (Size) 81.98 (1)
Ask (Size) 82.18 (1)
Prev. Close 79.16
Today's Range 78.60 - 83.07
52wk Range 73.31 - 129.93
Shares Outstanding 2,531,374,696
Dividend Yield 3.96%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%
The Dow Jones Industrial Average stocks average a 2% dividend yield through the first six months of 2025. Here are the top yields. 
Via Benzinga
Topics Stocks
Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?
The Dow Jones Industrial Average was up around 4% in the first half of 2025 with a large majority of the 30 stocks positive. 
Via Benzinga
Topics Stocks

Performance

YTD
-17.5%
-17.5%
1 Month
+7.3%
+7.3%
3 Month
-6.1%
-6.1%
6 Month
-17.8%
-17.8%
1 Year
-36.0%
-36.0%

More News

Read More
Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29
From Merck & Co., Inc.
Via Business Wire
HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
Via Investor's Business Daily
Peering Into Merck & Co's Recent Short Interest
Via Benzinga
1 Profitable Stock to Consider Right Now and 2 to Think Twice About
Via StockStory
3 Absurdly Cheap Stocks Ready for a Breakout
Via The Motley Fool
RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants
Via Benzinga
CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarm
Via Stocktwits
5 Biotech Stocks with Highly Anticipated Pending Results
Via Stocktwits
Topics Intellectual Property
Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise
Via Benzinga
ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
From Merck & Co., Inc.
Via Business Wire
2 Stocks Too Cheap to Ignore at These Prices
Via The Motley Fool
Topics Artificial Intelligence Lawsuit
RFK Jr. Overhauls CDC Vaccine Panel, Sparking Expert Backlash, Boycott From Top Medical Group
Via Benzinga
Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention
From Merck & Co., Inc.
Via Business Wire
Merck's Hypertension Drug Cuts Clinical Worsening Risk In Over 70% Of Patients On Double Background Therapy
Via Benzinga
Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)
From Merck & Co., Inc.
Via Business Wire
Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere
Via Benzinga
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Via Benzinga
2 Reasons to Watch MRK and 1 to Stay Cautious
Via StockStory
Topics Supply Chain
Nobody Wants To Touch Healthcare Stocks Now – That Might Be A Big Mistake
Via Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
MERCK & CO. INC. (NYSE:MRK) - A Strong Dividend Stock with Solid Fundamentals
Via Chartmill
IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer
From Merck & Co., Inc.
Via Business Wire

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 81.81
When was Merck & Co last traded?
The last trade of Merck & Co was at 07/01/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 207.09B
How many shares of Merck & Co are outstanding?
Merck & Co has 207B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.